Menu

From Scientific Idea to New Targeted Therapy – how to commercialize science

The Graduate Programme in Haematology & Oncology

Goals
How is a good scientific idea translated into a new registered therapeutic agent or commercialized diagnostic tool?

The PhD course deals with this question. The main theme is to follow the development of a new monoclonal antibody with anti-neoplastic properties starting from the identification of an attractive cellular target via early pre-clinical successes and pitfalls and through clinical evaluation to the final EMA registration as a new therapeutic.

The parallel goal of the course is to give the PhD student insight into commercial potentials of his/her own PhD project. If any, what then to do? What is the process and what is needed to go for a patent?

Finally, what are the challenges when going from a position as a university researcher to an employment in a commercial organisation, e.g. the pharmaceutical industry?

Methods:

  • Lectures by leading scientists, patent office specialists, and commercial directors
  • Interactive moderated break-out sessions with oral presentations by PhD students with focus on “What are the commercial potentials of my PhD-project”
  • Moderated poster sessions with presentations of the individual PhD projects

Course leaders:
Professor Niels Abildgaard, SDU, and Ass. Professor Kirsten Grønbæk, Copenhagen University in collaboration with the Danish Haematological Research Educational Network (Dansk Hæmatologisk Forskerskole Netværk)

Language:
English (and Danish in selected sessions)

Teachers:
Commercial industry:
Paul Parren, PhD, Senior Vice President and Scientific Director, Genmab, Utrecht, NL
Nikolai Constantin Brun, Vice President, Medical Department, Genmab A/S, Copenhagen
Mads Hansen, MD, Senior medical Advisor, Medical Department, Amgen A/S, Copenhagen Danish Health Board (Sundhedsstyrelsen):
Dorthe Meyer, MD, Senior Medical Officer

University:
Martin Røssel Larsen, professor, Human Clinical Proteom Center, SDU
Torben Barrington, professor, Department of Clinical Immunology, SDU
Torben Plesner, professor, Institute of Regional Health Sciences, SDU
Lars Stig Møller, Head of Office, Patent Office, SDU
Ann Zahle Andersen, PhD, Business Scouting Officer, Patent Office, SDU

Time and Venue:
Residential course held Thursday 14th – Friday 15th of March, 2013 at Hindsgavl Kursuscenter, Hindsgavl Alle 7, DK-5500 Middelfart. Phone: +45 6441 8800, http://www.hindsgavl.dk/ .

Number of participants: 25 (-30).

Course Fee
Free of charge for PhD students from the Faculty of Health Science, University of Southern Denmark (SDU).
DKK 4.604 for PhD students from other Danish Universities.
DKK 9.670 for other external participants.

Registration deadline: Monday February17, 2013. 

ECTS: 2.0 ECTS

 

 

To give you the best possible experience, this site uses cookies  Read more about cookies

Accept cookies